The kidney, a critical organ for waste filtration and fluid regulation, is the subject of a molecular mapping project that could reshape our understanding of renal health. Despite advances in ...

Autumn’s masterpiece: Sandy Stream Pond serves up a feast for the eyes that puts even the best pumpkin spice latte to shame. Photo credit: Beth Nedley It’s the kind of view that makes you forget about ...

Picture this: a vast wilderness where ancient forests meet rugged mountains, and crystal-clear lakes mirror the sky. No, it’s not Middle Earth – it’s Baxter State Park, Maine’s crown jewel of natural ...

Baxter's Vantive unit, in the process of being sold to Carlyle, is building an R&D center in Golden Valley. The kidney care unit develops and supports dialysis and other kidney disease therapies ...

This summer, after poring over a Baxter State Park trail map, I decided that Sentinel was the perfect location for my niece’s first major mountain hike in the park — and I’m happy to report that I was ...

The sale of the Kidney Care segment to Carlyle for $3.8 billion will significantly lower Baxter's net debt, though net proceeds are very modest at 0.7 times sales.

Baxter is targeting annual operational sales growth of 4%-5% following the sale of its Kidney Care segment, driven by innovation and market expansion. For 2025, the Company expects an adjusted ...

Baxter will use after-tax proceeds from the transaction to reduce its debt, according to the release. Vantive has more than 23,000 employees globally and had 2023 revenues of $4.5 billion ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, and funds managed by global investment firm Carlyle (NASDAQ:CG) today announced that they have signed a definitive agreement under which ...

Baxter International’s plans to streamline its operations are taking a big step with the proposed $3.8 billion sale of its kidney care business to private equity firm The Carlyle Group.

Shares of Baxter International (BAX) fell Tuesday after the company said it would sell its kidney treatment division to The Carlyle Group (CG) for $3.8 billion in cash.

NEW YORK, Aug 13 (Reuters) - Buyout firm Carlyle Group (CG.O), opens new tab struck a deal to acquire Baxter’s kidney-care unit Vantive for $3.8 billion, the companies said on Tuesday. The ...